Quetiapine

Quetiapine is a pharmaceutical-grade active ingredient classified as an Atypical Antipsychotic Dibenzothiazepine. Mediocon Inc supplies high-purity Quetiapine API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Quetiapine is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, and as adjunctive therapy for major depressive disorder. It acts by blocking dopamine D2, serotonin 5-HT2A, and multiple other receptors, providing a broad spectrum of antipsychotic and mood-stabilizing effects.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Schizophrenia (acute and maintenance treatment)
• Bipolar disorder (manic and depressive episodes)
• Adjunctive therapy for major depressive disorder
• Extended-release formulations for once-daily dosing

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings